Novo Nordisk Aktie
85,65
EUR
+3,59
EUR
+4,37
%
83,42
EUR
+4,22
EUR
+5,33
%
Novo Nordisk Aktie Analyse
| 20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 21.10.24 | Novo Nordisk Underperform | Bernstein Research | |
|
Werbung
|
|||
| 20.09.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
| 07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.08.23 | Novo Nordisk Sell | UBS AG | |
| 08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 12.07.23 | Novo Nordisk Sell | UBS AG | |
| 05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.06.23 | Novo Nordisk Sell | UBS AG | |
| 19.06.23 | Novo Nordisk Sell | UBS AG | |
| 12.06.23 | Novo Nordisk Sell | UBS AG | |
| 08.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.05.23 | Novo Nordisk Sell | UBS AG | |
| 22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.05.23 | Novo Nordisk Sell | UBS AG | |
| 04.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.04.23 | Novo Nordisk Sell | UBS AG | |
| 18.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 14.04.23 | Novo Nordisk Sell | UBS AG | |
| 13.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.02.23 | Novo Nordisk Sell | UBS AG | |
| 20.01.23 | Novo Nordisk Sell | UBS AG | |
| 09.01.23 | Novo Nordisk Sell | UBS AG | |
| 05.01.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.11.22 | Novo Nordisk Sell | UBS AG | |
| 23.08.22 | Novo Nordisk Sell | UBS AG | |
| 17.08.22 | Novo Nordisk Sell | UBS AG | |
| 05.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.06.22 | Novo Nordisk Sell | UBS AG | |
| 29.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.02.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |